Article 2
Getzen’s Health Economics & Financing, 5th Edition
Copyright © John Wiley & Sons, Inc.
Chapter 11: Pharmaceuticals
QUESTIONS
Which are most important in the pharmaceutical industry: fixed costs or variable costs?
How many drugs do Americans take? Who pays for them?
What events led to the regulation of prescription drugs by the Food and Drug Administration (FDA)?
Are patents a cost or an asset?
Why is so much more spent on marketing drugs than on marketing surgery or psychotherapy?
QUESTIONS cont.
How profitable is the drug industry?
Do patents raise or lower the productivity of research?
Do generic drugs replace or compete with brand-name drugs?
How are prescription costs “managed” by insurance companies?
What are the major costs in developing a new drug?
11.1 PHARMACEUTICAL REVENUES: SOURCES OF FINANCING
- Inpatient Pharmaceuticals
11.2 USES OF FUNDS
- Retail Pharmacies
- Wholesalers
- Insurance Companies and PBMs
- Pharmaceutical Firms
- Cost Structure
11.3 HISTORY AND REGULATION OF PHARMACEUTICALS
11.4 RESEARCH AND DEVELOPMENT
11.5 PHARMACOECONOMICS AND TECHNOLOGY ASSESSMENT
11.6 INDUSTRY STRUCTURE AND COMPETITION
- Value, Cost and Marketing
- The Role of Middlemen: Distribution versus Marketing
- Research Productivity
Copyright 2013 John Wiley & Sons, Inc.